Company intelligence / Profile preview

Wugan Pharmaceutical

Suzhou/Wujiang District/Tongli Town, Jiangsu, Chinavolza.com ↗

Ownership: Private
Development stage: Commercial

Overview

Wugan Pharmaceutical is a Chinese API and intermediate manufacturer specializing in small-molecule sulfonamide antibiotics primarily for veterinary use. It is GMP-certified and holds US FDA certification for its products, indicating global export capabilities. Founded in 1987, it is a significant producer in the veterinary drug market in China.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Veterinary

Drug pipeline

4 assets

sulfanilamide

Commercial

Indications: Veterinary

3 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Wugan Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wugan Pharmaceutical.

Explore the full profile